The health of this generation and the next begins with ensuring that pregnant women and their newborns get appropriate health care. According to SAMHSA’s latest National Survey on Drug Use and Health, the number of pregnant women with opioid use disorder (OUD) has more than doubled and the number of infants born with neonatal abstinence syndrome (NAS) has grown fivefold. Reducing these numbers means getting pregnant women with OUD the health care they need to reduce the chance of prenatal opioid exposure and NAS.Congress passed the Protecting Our Infants Act of 2015 (POIA) to respond to the unmet needs of pregnant women and their newborns.
Main page content
There has been a five-fold increase in babies born with Neonatal Abstinence Syndrome (NAS) from 2000 to 2012. These babies are a part of why HHS has made addressing the opioid epidemic a Department-wide priority.In collaboration with partners across federal government, SAMHSA is sharpening its focus on opioid-dependent pregnant women. And with a $1 billion, two-year investment of new, mandatory funding in the President’s Fiscal Year (FY) 2017 Budget proposal to bolster our efforts, we’re expanding and intensifying our work to prevent and treat opioid dependence, including identification and treatment of NAS.
Expanding access to life-saving treatment.